InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
77%
T+90 mean return
+3.2%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by DELANEY MARK E, Directeur Commercial. Insider active across 1 company, notably Quest Diagnostics INC. Aggregated, 19 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €202k. Activity tracked since 23 February 2023. The latest transaction was disclosed on 20 April 2026 (L). Regulator: SEC (Form 4). All data is openly available.
Declarations19 total
37 shares@ US$194.6960.0000% mcap35.7% of flowCommon StockSEC:0001022079-26-000044:0
15 shares@ US$189.0770.0000% mcap14.3% of flowCommon StockSEC:0001022079-25-000225:0
17 shares@ US$167.491Common StockSEC:0001022079-25-000184:0
874 shares@ US$175.7210.8% of flowCommon StockSEC:0001022079-25-000132:0
25 shares@ US$164.4210.3% of flowCommon StockSEC:0001022079-25-000126:0
256 shares@ US$166.713.1% of flowCommon StockSEC:0001022079-25-000100:0
5,317 shares@ US$173.7468.5% of flowCommon StockSEC:0001022079-25-000086:0
214 shares@ US$171.752.7% of flowCommon StockSEC:0001022079-25-000069:0
242 shares@ US$169.713.1% of flowCommon StockSEC:0001022079-25-000048:0
1,815 shares0Common StockSEC:0001022079-25-000032:0
403 shares@ US$164.30315.0% of flowCommon StockSEC:0001022079-25-000020:0
4 shares@ US$158.0250.0% of flowCommon StockSEC:0001022079-25-000014:0
4 shares@ US$149.3880.0% of flowCommon StockSEC:0001022079-24-000199:0
6 shares@ US$146.9840.1% of flowCommon StockSEC:0001022079-24-000168:0
170 shares@ US$128.111.6% of flowCommon StockSEC:0001022079-24-000089:0
225 shares@ US$126.362.0% of flowCommon StockSEC:0001022079-24-000077:0
2,348 shares0Common StockSEC:0001022079-24-000030:0
170 shares@ US$134.251.6% of flowCommon StockSEC:0001022079-23-000073:0
1,919 shares0Common StockSEC:0001022079-23-000029:0
19 of 19 declarations
About DELANEY MARK E
Mark E. Delaney is the Senior Vice President and Chief Commercial Officer of QUEST DIAGNOSTICS INC. In this role, he is responsible for the commercial strategy and business development of the company. His expertise in commercial management is crucial for the growth and innovation of Quest Diagnostics.
